Skip to main content
Clinical Trials/NCT06342869
NCT06342869CompletedNot Applicable

Comparison of the Effects of Lidocaine and Articaine Used for Buccal Infiltration and Supplemental Palatinal Infiltration Anesthesia in Teeth With Irreversible Pulpitis

Akdeniz University2 sites in 2 countries80 target enrollmentStarted: April 1, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
80
Locations
2
Primary Endpoint
Assessment of complementary palatinal anesthesia with VAS

Study Overview

Brief Summary

Objective: The aim of this study was to compare the effects of articaine or lidocaine in buccal infiltration or palatal infiltration in addition to buccal infiltration in maxillary first or second molars with irreversible pulpitis.

Method: Among the patients who applied to Akdeniz University Faculty of Dentistry Endodontic Clinic for the treatment of maxillary molars with irreversible pulpitis, 80 volunteers who met the criteria were included in the study. Eighty patients were divided into 4 groups (n = 20). 1. group buccal infiltration with 4% articaine containing 1:100,000 epinephrine, 2. group buccal infiltration with 2% lidocaine containing 80,000 epinephrine, 3. group buccal and palatinal infiltration with 4% articaine containing 1:100,000 epinephrine, 4.group buccal and palatinal infiltration with 2% lidocaine containing 80.000 epinephrine. Pain during the endodontic procedure was determined and recorded according to the Heft Parker visual analog scale.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • The patient must be a healthy individual between the ages of 18 and 65 who is classified as ASA I and II.
  • No allergy to local anesthetic substances to be used in the study
  • Upper maxillary molars with irreversible pulpitis whose vitality has been proven by pulp tests, with no radiolucency at the root tip
  • Not having used any painkillers, antibiotics, antidepressants and sedative drugs in the last 12 hours
  • Being capable of understanding the Pain scale

Exclusion Criteria

  • Allergy to local anesthetics
  • Failure to respond to the cold test and electric pulp test performed on the relevant tooth
  • Radiolucent lesion in the apical part of the relevant tooth on periapical radiography
  • No vital tissue is encountered when the pulp chamber is opened

Outcomes

Primary Outcomes

Assessment of complementary palatinal anesthesia with VAS

Time Frame: 10 minutes after anesthesia is performed

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Damla Kırıcı

associate professor

Akdeniz University

Study Sites (2)

Loading locations...

Similar Trials